Medtronic to Acquire Scientia Vascular

March 10, 2026—Medtronic announced it has entered into a definitive agreement to acquire Scientia Vascular, a developer of access products for the treatment of complex neurovascular conditions.

According to the press release, Scientia’s portfolio of guidewires and catheters can be integrated with Medtronic’s existing suite of neurovascular products. Scientia is a private company operating in Salt Lake City, Utah, with approximately 310 employees. It was founded by current Chief Technology Officer John Lippert.

David Fiorella, MD, Director of the Cerebrovascular Center at Stony Brook Medicine in Stony Brook, New York, commented on Scientia’s portfolio in the press release.

“Microwires and microcatheters are required for all neurointerventional cases,” stated Dr. Fiorella. “Correspondingly, better microwires and microcatheters make every single case technically easier, faster, and ultimately safer for patients. This revolutionary microwire technology has enabled—and will continue to enable—access and simplify the neurovascular procedures we do.”

Medtronic advised that the acquisition is expected to close in the first half of FY 2027, subject to regulatory approvals and satisfaction of other closing condition. It is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments after the acquisition.